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Abstract
The regulation of cellular zinc uptake is a key process in the overall mechanism governing mammalian zinc homeostasis and
how zinc participates in cellular functions. We analyzed the zinc transporters of the Zip family in both the brain and liver of
zinc-deficient animals and found a large, significant increase in Zip10 expression. Additionally, Zip10 expression decreased
in response to zinc repletion. Moreover, isolated mouse hepatocytes, AML12 hepatocytes, and Neuro 2A cells also respond
differentially to zinc availability in vitro. Measurement of Zip10 hnRNA and actinomycin D inhibition studies indicate that
Zip10 was transcriptionally regulated by zinc deficiency. Through luciferase promoter constructs and ChIP analysis, binding
of MTF-1 to a metal response element located 17 bp downstream of the transcription start site was shown to be necessary
for zinc-induced repression of Zip10. Furthermore, zinc-activated MTF-1 causes down-regulation of Zip10 transcription by
physically blocking Pol II movement through the gene. Lastly, ZIP10 is localized to the plasma membrane of hepatocytes
and neuro 2A cells. Collectively, these results reveal a novel repressive role for MTF-1 in the regulation of the Zip10 zinc
transporter expression by pausing Pol II transcription. ZIP10 may have roles in control of zinc homeostasis in specific sites
particularly those of the brain and liver. Within that context ZIP10 may act as an important survival mechanism during
periods of zinc inadequacy.
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Introduction
Zinc is an essential dietary component. Its functions in biology
are numerous, but can be separated into three main categories:
catalytic, regulatory, and structural roles. For example, greater
than ten percent of the human genome codes for zinc-containing
proteins [1]. Not surprisingly, deficiency of this micronutrient is
associated with diverse pathology, including impaired immunity,
retarded growth, neurological disorders, and delayed wound
healing [2]. However, the mechanisms leading to these clinical
manifestations of zinc deficiency remain elusive.
Tight-control of cellular zinc homeostasis is maintained by
proteins that can affect the amount of available zinc. Metal
transporters of the ZRT/ IRT-like protein (ZIP) family and zinc
transporter (ZnT) family, as well as zinc-binding by metallothio-
neins (MTs), maintain control of intracellular zinc levels [3,4], .
Currently, 10 ZnT and 14 ZIP transporters have been identified.
The ZnT proteins function in cellular zinc efflux or vesicular
storage. ZnT1 was the first zinc transporter to be characterized,
and is expressed in all tissues, localizing to the plasma membrane
of cells [5]. Subsequent studies revealed zinc-regulated expression
of ZnT1 in the intestine [6], and that zinc regulates expression of
ZnT1 through activation of the metal response element-binding
transcription factor MTF-1 [7].
Metal-inducible genes regulated by MTF-1 include the
Metallothioneins (Mt), glutamate–cysteine ligase heavy chain
(cGCShc) which codes for an oxidative stress-related protein [8],
and the aforementioned ZnT1. MTF-1 responds to changes in
intracellular zinc and other heavy-metals (e.g., Cadmium and
Copper) where upon metal-occupancy there is translocation from
the cytosol to the nucleus. Subsequently this transcription factor
binds to metal response elements (MREs) located in the proximal
promoters of metal responsive genes, resulting in an increased rate
of transcription [9–11]. The importance of MTF-1 to zinc
homeostasis and mammalian physiology is accentuated by the
fact that ablation of the gene leads to severe liver degeneration and
embryonic lethality by day 14 of gestation in mice [12].
Subsequent investigation of a liver-specific conditional knockout
of the MTF-1 gene in adult mice revealed a second MTF-1
regulated zinc transporter gene Zip10 [13].
Among the 24 zinc transporters, a number have exhibited
responsiveness to dietary zinc intake [3]. Of those, ZnT1 and Zip4
have received the most attention. Mechanistically, during dietary
zinc restriction, down-regulation of ZnT1 occurs through de-
creased MTF-1 activation and ZnT1 promoter binding [7]. The
functional outcome of less ZnT1 expression is decreased cellular
zinc efflux. Concomitant to decreased ZnT1 expression is an
increase in the intestinal, apically-localized zinc transporter, ZIP4,
which results in increased dietary zinc absorption in response to
zinc restriction [14,15]. Zip4 expression does not appear to be
MTF-1 regulated. Zip10 belongs to the Zip class of zinc
transporters which oppose the ZnT transporters by increasing
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or vesicular efflux [3,4,16]. Activation of MTF-1 by cadmium, and
subsequent binding to the Zip10 promoter, led to inhibitionof Zip10
expression [13], an observation opposite to that seen with ZnT1.
Similar observations have been made for Zip10 expression using
different model systems [17–20]. In silico promoter examination
and EMSA analysis revealed one functional MRE located at +17
relative to the Zip10 transcription start site [13]. This was the first
demonstration of metal-dependant transcription repression of a
gene by MTF-1. Here we demonstrate the dynamic responsiveness
of Zip10 in mouse liver and brain to zinc restriction and excess.
Furthermore, ChIP analysis revealed in vivo association of MTF-1
with the Zip10 promoter in mouse hepatocytes after zinc
supplementation. In addition, MTF-1 siRNA and luciferase
reporter constructs show repression of Zip10 expression occurs via
MTF-1 activity and DNA binding to the downstream MRE of
Zip10. These experiments identify ZIP10 as an important zinc
transporter involved in maintenance of brain and liver zinc
homeostasis, as well as revealing a novel role for MTF-1 in the
regulation of zinc transport.
Materials and Methods
Mice and Treatments
Adult male CD-1 strain mice (Charles River Breeding Labora-
tories) that ranged in age from 6 to 8 weeks were housed and fed as
described in detail [15]. Mice were fed either a zinc deficient (ZnD:
,1 mg/kg) or zinc adequate (ZnA: 30 mg/kg) diet, individually for
up to 21 days. Additionally, ZnD mice were fed a supplemental
(ZnR: 180 mg/kg) zinc diet for zinc repletion. Blood was collected
by cardiac puncture under anaesthesia for measurement of the
serum zinc concentration by atomic absorption spectroscopy. The
protocol was approved by the University of Florida Institutional
Animal Care and Use Committee (protocol #200903621).
Antibody Production
The peptides KRNHKCDPEKE and SASLSLPLVLQSG were
used to produce antibodies in rabbits to ZIP10 and MTF-1,
respectively. Peptides were analyzed by mass spectrometry to
assess purity. An N-terminal cysteine was added to each peptide to
facilitate conjugation to keyhole limpet hemocyanin (KLH) and for
conjugation to Sulfo-link (Pierce) matrix for affinity chromatogra-
phy. These methods are described in [6,15,18]. Specificity of the
ZIP10 antibody has been demonstrated previously [18]. MTF-1
antibody was ChIP-grade and was purchased from Santa Cruz
Biotechnology (SC-26844).
Immunocytochemistry of Mouse Liver and Hepatocytes
Liver sections from mice that had been anesthetized and
exsanguinated were fixed with 10% formalin in PBS, embedded in
paraffin, cut as 5-mm sections, and mounted. Incubation with the
affinity purified primary antibodies (10 mg/ml) was followed by
addition of anti-rabbit IgG-Alexa 594 conjugate or anti-goat IgG-
Alexa 488 conjugate (Molecular Probes). Detection and visualiza-
tion of ZIP10 in primary hepatocytes and AML12 hepatocytes was
performed as previously described [21]. As negative controls,
respective peptides were incubated with the primary antibody
before exposure to the tissue section, as previously described
[15,18]. Counterstaining of nuclei was performed with 49,6-
diamidino-2-phenylindole (DAPI).
Immunohistology of Mouse Brain
The mice were anesthetized and then perfused intracardially
with 4% paraformaldehyde. After perfusion, the brain was fixed
for 24 h in 4% paraformaldehyde and transferred to 70% ethanol
until being embedded in paraffin. The entire brain was serially
sectioned (4 mm sections), and every 10th section was stained with
hematoxylin and eosin (H&E). Immunostaining of adjacent
sections was performed according to a standard streptavidin-
peroxidase procedure and as previously described [22]. Endoge-
nous peroxidise activity was suppressed with 3% H2O2. Tissues
were incubated with the affinity purified ZIP10 primary antibody
(1:1000 dilution) in 3% normal serum and 0.1% Triton-X,
followed by a rabbit anti-goat secondary biotinylated antibody
(Vector, Burlingame, CA) and lastly were incubated with avidin-
biotin-peroxidase, and visualized with the DAB chromagen
(Vector, Burlingame, CA).
Western Blot Analysis of Membrane Proteins
Liver samples were homogenized immediately in cold buffer
(20 mM Hepes, pH 7.4/1 mM EDTA/300 mM mannitol) con-
taining a protease inhibitor mixture (Pierce) by using a Potter-
Elvehjem homogenizer. Membrane protein preparations were
prepared by centrifugation (100,0006 g) after nuclei and debris
were first removed by centrifugation at 1,0006 g. The proteins
were resolved by PAGE using 10% gels and transferred to a
nitrocellulose membrane (Schleicher and Schuell), then incubated
with the appropriate affinity-purified antibody, and finally
visualized by chemiluminescence detection. These methods have
been described previously [6,15]. Antibodies against actin (Sigma)
and Na/K ATPase (Santa Cruz) were used to analyze protein
loading of total cell lysate or the membrane fraction, respectively.
Hepatocyte isolation and culture
Mice were anesthetized and hepatocytes isolated as previously
described [21]. Viability was assessed with Trypan Blue. Only
hepatocytes suspensions with .95% viability, were used in
experiments. Following selective attachment of parenchymal cells,
medium in each well was changed, and these culture conditions
were continued for 18–22 h.
Cell Culture and treatments
AML12 mouse hepatocytes (ATCC) were grown in DMEM/F-
12 containing 10% (v/v) FBS, dexamethasone (40 ng/mL), and
ITS (insulin, Tf, selenium) supplement (BD Biosciences). The
Neuro 2A cells (ATCC) were maintained in DMEM with 10%
FBS. Medium also contained penicillin, streptomycin, and
amphotericin B (Sigma). The hepatocytes and neuroblastoma
cells were maintained as previously described [21]. In some
experiments the cultures contained either TPEN (4 mM), a
membrane permeable chelator or DTPA (50 mM), a hydrophobic
membrane impermeable zinc chelator [23,24].
Relative mRNA quantification
Total RNA was isolated from liver, brain, AML12 hepatocytes,
and Neuro 2A cells using TRIzol (Invitrogen) and treated with
Turbo DNase (Ambion) to eliminate any DNA contamination.
Quantitative PCR was used to determine the relative amount of
Zip10 mRNA. DNA amplification was ruled out through no RT
reactions. The PCR reaction conditions were 95uC for 10 min,
followed by 40 cycles of 95uC for 15 s, 60uC for 60 s, and one final
cycle at 60uC for 60 s. After PCR, melting curves were acquired to
ensure that a single product was amplified during the reaction.
The primers used for PCR amplified the exon 10 region of Zip10
mRNA and were as follows: sense primer, 59- TGGCTTACA-
TAGGAATGCTCATAGG-39, and antisense primer, 59- TGC-
GAAGATCCAGAGTGTGATG-39, Zip10 hnRNA sense primer
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er 59–CCATGTGAATGACCATGTCC–39. Transcript abun-
dances were normalized to 18s rRNA sense primer, 59-
AGTCCCTGCCCTTTGTACACA-39, and antisense primer,
59-GATCCGAGGGCCTCACTAAAC-39, or TATA-binding
protein (TBP) (ABI). The results are expressed as arbitrary units
of Zip10 normalized to 18S rRNA, or TBP mRNA, where stated
and based on a RNA standard curve. The PCR reactions were
performed in duplicate for each sample, and samples were
collected from at least three independent experiments.
ChIP Analysis
Chromatin immunoprecipitation was performed as described
previously [21,25]. The reaction mixtures were incubated at 95uC
for 10 min, followed by 40 cycles of amplification at 95uC for 15 s
and 60uC for 60 s. Primers for Zip10 were Zip10TSS sense primer
59-AGAATACACGACTGGGTGCAG-39, and antisense primer
59–TGGGGGAGGGAATGTAAAC–39; Zip10 exon2 sense
primer 59–TGCTCCAAGTGACACAAAGC–39, and antisense
primer 59–CGCTAGTTACCGCACTTAACG–39; Zip10 ex-
on10 sense primer 59–AATGGAGCGGTCAGTGTTTG–39,
and antisense primer 59–GTGGCATGGGATGTAAACAG–39;
Zip10 Upstream sense primer 59–AATAAGGCCCAGCACT-
GAAG–39, and antisense primer 59–ACATTTACCCCTGTGG-
CATC–39.
Zip10 promoter construction and mutagenesis
The Zip10 promoter construct was cloned (22k bt o+1k b
relative to the Zip10 TSS) from BAC DNA (RP23-374B12), using
PCR with primers containing EcoRV and HindIII sites appended
to the 59 ends. The PCR product was then subcloned into the
pGemT–Easy plasmid using T/A cloning and further inserted into
the pGL4.11 plasmid (Promega) by using the same EcoRV and
HindIII restriction sites, immediately upstream of the luciferase
gene. Plasmid constructs were confirmed by DNA sequencing.
The Zip10 Luc mutant construct containing the 3 kb promoter
was created using site-directed mutagenesis (Quick Change II,
Startagene). The oligonucleotides used to generate the mutation of
the MRE site were 59–GTACCGAGCGGAGAGGAGAGGCC-
TACGGCACTCG–39 and 59–CGAGTGCCGTAGGCCTC-
TCCTCTCCGCTCGGTAC–39. Mutation of the MRE site
introduced a novel StuI restriction site that was used for screening
of mutated clones. Further confirmation of mutations and integrity
of promoter fragments was performed by DNA sequencing. MRE
sequences were identified via the Genomatix and USCS Genome
Bioinformatic databases.
Transfection and luciferase assay
AML12 mouse hepatocytes (American Type Culture Collec-
tion) were seeded at 1610
5 cells/well in 24-well plates culture
conditions were described previously [21]. Transfection began
12 h after seeding with 15 nM (final concentration) of siRNA for
mMTF-1 or mZip10 (Smart Pool, Dharmacon) using HiPerFect
transfection reagent (Qiagen), and was carried out for 48 h. For
the luciferase assays, AML-12 cells were seeded in 12- or 24-well
plates and transfected with pGL4.11 plasmid and the Renilla
luciferase control plamids pRL-SV40 or pGL4.73 (Promega) by
using Effectene reagent (Qiagen). After 48 h of incubation, the
medium was replaced by medium with or without 40 mM ZnSO4
or 4 mM TPEN for 4 h. Luciferase activities were measured with a
Dual-Luciferase Assay System (Promega) with a SpectraMax M5
(Molecular Devices) in luminometer mode following the manu-
facturer’s protocol. The raw values of firefly luciferase were
normalized to Renilla luciferase that had been transfected
concurrently in all the assays to correct for differences in
transfection efficiency. The Renilla luciferase was stable through-
out the experiments, and not significantly affected by zinc status.
The promoter activity assays were measured in triplicate in each
experiment and shown as fold-change relative to control. At least
three sets of independent experiments were performed for each set
of constructs.
Zinc uptake by hepatocytes
AML12 hepatocytes were incubated as above with 5 mM
FluoZin-3AM (Invitrogen), a cell-permeable zinc fluorophore, in
serum-free medium for 30 min. Intracellular zinc accumulation
was measured as previously described [26].
Statistical analysis
Data are presented as the means 6 S.D. Significant changes
between two groups were determined by Student’s t-test. Two-way
ANOVA and Bonferroni’s post-test were used for multiple
comparisons. Statistical significance was set at p,0.05.
Results
Dietary zinc modulates Zip10 expression in mice
By utilizing the gene expression portal BioGPS, we narrowed
our search for tissues expressing Zip10 at high levels to the liver
(median value) and the brain (10-fold median value) [27]. For
comparative purposes, our initial study of Zip10 began by
screening changes in mRNA expression of all Zip transporters in
liver and brain tissue of mice following three weeks of dietary zinc
deficiency. This murine model of zinc restriction has been used
extensively [15,18]. Evidence for creation of zinc deficiency is the
reduction in serum zinc concentration. Although changes in other
transporters were observed (e.g., Zip9 and Zip13), the most robust
change in gene expression was seen in Zip10 (Figure 1A). Average
Ct values for the Zip transporter mRNA assays are provided in
Table S1. Analysis of relative transcript abundance by qPCR
revealed a significant 2-fold increase in liver, and 3-fold increase
in brain Zip10 expression from mice maintained on the zinc-
deficient diet. Of interest is the relative 30-fold higher Zip10
mRNA expression in brain versus liver tissue (Figure S1). Western
analysis of ZIP10 protein abundance from liver and brain
(Figure 1B) showed similar increases in expression from mice fed
the zinc-deficient diet. These increases were 1.6 fold or greater.
In addition, immunohistochemical analysis with the anti-ZIP10
antibody revealed a mainly cytoplasmic distribution of ZIP10 in
liver of ZnA mice (Figure 1C). The cytoplasmic distribution of
ZIP10 is interpreted as ZIP10 associated with endocytotic
processing and/or movement of the protein to the plasma
membrane. However, under ZnD conditions, ZIP10 is localized
to distinct intracellular membranes and the plasma membrane.
The most prominent areas of ZIP10 localization in the forebrain
were the posterior lateral, posterior internal and the posterior
medial striatum terminalis. The lateral globus pallidus (LGP),
sublentic amygdala (SLEA) and dorsal lateral septal nuclei also
showed marked ZIP10 expression. Staining was markedly
increased in those sections from brains of the ZnD mice. The
ventral tegmental area (VTA) was also highly immunopositive for
ZIP10 and was increased in the ZnD mice. These results indicate
that Zip10 is abundantly and differentially expressed in both liver
and brain tissue of mice and responds to dietary zinc status.
Zip10 responds quickly to dietary zinc repletion
After 7 d of zinc depletion, the serum zinc concentration
dropped to approximately one-half normal levels (Figure 2A). The
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21526Figure 1. Restriction of dietary zinc increases Zip10 expression in liver and brain. (A) Total RNA extracts from liver and brain tissue of ZnD
or ZnA mice were analyzed by qRT-PCR. Values shown are for those Zip mRNAs up-regulated by dietary zinc restriction. They are expressed as relative
to 18 rRNA in a log2-scale (mean 6 SD, n=4). Statistical significance at P,0.05 or greater is indicated with an asterisk since values from the ZnA mice
are expressed as 1.0 only the SD is shown. (B) Plasma membrane protein fractions from liver (upper panel) and brain (lower panel) tissues of ZnD
or ZnA mice were isolated and separated by SDS-PAGE. Western blotting was performed by using an anti-ZIP10 antibody. Blots were then stripped
and re-probed using an anti-Na/ K ATPase antibody. Representative blots are shown. (C) Sections of liver (upper panel) and brain (lower panel)
from ZnA and ZnD mice. Immunolocalization of ZIP10 was performed by using the anti-Zip10 antibody, and visualization was achieved with an Alexa
Repression of Zip10 expression by MTF-1 and Zinc
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restriction (Figure 2B). By providing animals with supplemental
zinc (ZnR) in the diet for 1 d following the 7-day depletion (ZnD),
Zip10 mRNA abundance was significantly decreased, while serum
zinc was significantly increased. The changes in serum zinc
concentrations serve as a positive control of the in vivo
effectiveness of the nutritional treatments used. Western blot
analyses of liver membrane proteins showed that, by day 7 of
depletion, ZIP10 was markedly increased (Figure 2C). However,
following only 1 d of repletion of the mice with the ZnR diet,
ZIP10 levels decreased dramatically. These results show that the
Zip10 gene is capable of rapidly responding to the dietary zinc
supply.
Regulation of Zip10 expression by zinc
To further investigate the relationship between Zip10 and zinc,
we used primary and AML12 mouse hepatocytes as models of liver
cells, and Neuro-2A cells as representative neuronal cells.
Treatment of these cell types with increasing amounts of zinc
resulted in a dose-dependant repression of Zip10 transcript
abundance (Figure 3A). Because no significant differences were
seen between the responses of the cell lines tested, the AML12 cell
line was used for subsequent experiments. To simulate zinc
deficiency, AML12 hepatocytes were incubated with either TPEN
(4 mM) or DTPA (50 mM) both zinc chelators, which lead to a 4-
fold increase in Zip10 mRNA levels (Figure 3B). Furthermore, the
response of the hepatocytes to zinc repletion was similar to the in
vivo liver response (Figure 3C). The AML12 hepatocytes
responded very quickly to medium supplemented with zinc by
down-regulating Zip10 expression within 30 min following zinc
addition.
The differential response of the hepatocytes to zinc availability
was also examined at the protein level. To determine ZIP10
protein expression, 8 h following zinc or TPEN treatment,
membrane proteins were isolated from the AML12 hepatocytes
for western analysis. ZIP10 abundance (Figure 3D) closely
followed that found for Zip10 mRNA. A comparable increase
in ZIP10 was observed with DTPA (data not shown).
As an initial approach to determine whether zinc is modulating
Zip10 expression through a transcriptional mode of regulation, we
Figure 2. Dietary zinc repletion decreases Zip10 expression. (A) Serum zinc concentrations were measured in mice fed the ZnD or ZnA diets
for 7 d, followed by one group of ZnD mice receiving a zinc-repletion diet (ZnR) for 1 d. (B) Relative abundance of Zip10 mRNA between ZnA, ZnD,
and ZnR groups is shown normalized to 18s rRNA. Values are given as means 6 SD. Values with a different superscript are significantly different at
P,0.05 or greater, n=5. (C) Representative western blot analysis (upper panel) and relative densitometry normalized to Na/K ATPase (lower
panel) of total liver membrane proteins showing the decrease in ZIP10 abundance upon zinc repletion.
doi:10.1371/journal.pone.0021526.g002
fluor594 secondary antibody or Horseradish immunoperoxidase. Representative regions of the sublentic amygdala (SLEA) and lateral globus pallidus
(LGP) and the mesencephalic ventral tegmental area (VTA) of ZnA and ZnD mice were examined.
doi:10.1371/journal.pone.0021526.g001
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hnRNA [28] post TPEN treatment (Figure 3E). In agreement with
zinc deficiency inducing Zip10 expression by increasing gene
transcription, Zip10 hnRNA mirrored the mRNA. Furthermore,
AML12 hepatocytes were exposed to 5 mM TPEN for 3 h in the
presence or absence of 5 mg/mL actinomycin D, an inhibitor of
RNA synthesis. As shown by the results of qPCR (Figure 3F),
cotreatment with actinomycin D blocked the TPEN-induced
increase in Zip10 mRNA.
Zinc regulated expression of Zip10 occurs through
activation of MTF1
Mechanistically, exposure of cells to zinc causes a rapid
translocation of MTF-1 from the cytoplasm to the nucleus
Figure 3. Zinc availability modulates Zip10 expression. (A) The relative abundance of Zip10 mRNA was measured by qRT-PCR and compared
in primary and AML12 mouse hepatocytes, and Neuro2A cells after being supplemented with increasing amounts of zinc (0–200 mM) for 3 h. (B)
AML12 hepatocytes were treated for 3 h with 40 mM zinc, or one of the zinc chelators DTPA (50 mM) or TPEN (4 mM) to deplete cellular zinc levels. (C)
AML12 hepatocytes were pre-treated with TPEN (4 mM) for 3 h to 6 h to increase Zip10 mRNA abundance. Then a subset of hepatocytes was given
supplemental zinc (40 mM) for 3 h. Cells were harvested at the times indicated and Zip10 mRNA levels were measured by qRT-PCR. (D) Western
analysis of AML12 hepatocytes after treatment with 40 mM zinc or 4 mM TPEN. Representative blots are shown. (E) Time-course comparing Zip10
mRNA and hnRNA relative to TBP mRNA in AML12 hepatocytes post-TPEN treatment. (F) Zip10 mRNA abundance relative to TBP mRNA after pre-
treatment of hepatocytes with Actinomycin D for 1 h followed by exposure to TPEN for 3 h. Data are expressed as mean 6 SD, and values with a
different superscript are significantly different at P,0.05 (n=3). Data are from a representative experiment that was repeated multiple times.
doi:10.1371/journal.pone.0021526.g003
Repression of Zip10 expression by MTF-1 and Zinc
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e21526[9,10] and up-regulation of the zinc-responsive genes Mt and
ZnT1 occurs via binding of MTF-1 to the corresponding
proximal-promoter region. However, through EMSA analysis,
M T F - 1w a ss h o w nt ob i n dt oad o w n s t r e a mM R Eo fZip10
(i.e., +17 relative to the TSS) after Cd exposure [13]. However,
this downstream MRE of Zip10 was proposed through
bioinformatic analysis, not direct sequencing. Therefore, to
investigate the role of this putative downstream MRE in Zip10
regulation, we first performed 59 RACE from total RNA taken
from liver and brain tissues of ZnD animals. The results
revealed that (Figure S2) a single band was amplified,
indicating that one TSS exists. Upon sequencing, the transcript
matched exactly with the public record NM_172653.2 with one
MRE located 17 bp downstream of the TSS. Our next step was
to determine if MTF-1 was mediating the zinc sensitivity of
Zip10. By using siRNA directed against MTF-1, a clear
decrease in MTF-1 expression was evident 48 h post siRNA
transfection (Figure 4A). As a positive control for zinc
sensitivity and MTF-1 transcriptional control, Mt mRNA levels
were measured post MTF-1 siRNA transfection . Following
transfection of MTF-1 siRNA, the ability of zinc to induce Mt
expression was severely hindered. After finding a significant
decrease in MTF-1 expression and a lack of increase in Mt
expression, we examined the Zip10 mRNA levels following zinc
treatment in cells lacking MTF-1. In addition, ZIP10 protein
levels were elevated in cells lacking MTF-1 (Figure 4B).
Moreover, the knockdown of MTF-1 was able to reverse the
dose-dependent repression of Zip10 by zinc, and this reversal
was maintained for 12 h (Figure 4C).
MTF-1 binding to the Zip10 MRE is required for gene
repression
To further investigate the roles of MTF-1 and the MRE of
Zip10, we cloned a fragment comprising 22k bt o+1 kb of the
Zip10 gene into the luciferase vector pGL4.11. This allowed us to
determine the functional capacity of the exonic MRE located
downstream of the TSS. Upon transfection into AML12 cells, the
promoter activity was repressed by addition of 100 mM zinc
(Figure 5A). In contrast, treatment of the transfected cells with
TPEN Zip10 promoter activity was markedly increased. In
addition, co-transfection with MTF-1 siRNA reduced the response
of the Zip10 reporter to activation by 100 mM zinc MTF-1 siRNA
had no effect on the influence of TPEN. Further, the MRE upon
being mutated lost responsiveness to zinc. These results show that
Figure 4. MTF-1 knockdown increases Zip10 expression. (A) AML12 hepatocytes were transfected with MTF-1 siRNA and allowed to incubate
for 48 h. Increasing amounts of zinc were subsequently added to the culture medium, and hepatocytes were incubated for an additional 3 h. The
relative abundance of MTF-1 (upper panel), MT (middle panel), and Zip10 mRNAs (lower panel) were analyzed by qRT-PCR. (B) The effect of MTF-
1 knockdown on ZIP10 protein levels was further analyzed by western blotting with actin used as a loading control. (C) Time-course measuring the
response of Zip10 to zinc addition following MTF-1 transfection, as described above. Values with a different superscript are significantly different from
the corresponding negative control value at P,0.05 or greater. n=3.
doi:10.1371/journal.pone.0021526.g004
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+17, responds to zinc as observed in vivo with mouse liver or
AML12 hepatocytes, indicating the MTF-1 is necessary for the
zinc repression of the reporter.
MTF-1 regulates Zip10 expression through obstruction of
Pol II elongation
In an attempt to determine if MTF-1 is responsible for in vivo
zinc-regulated expression of Zip10, we exposed the hepatocytes to
zinc restricted and zinc supplemented conditions (i.e., 4 mM
TPEN and 100 mM zinc, respectively) and analyzed the protein-
DNA interactions through ChIP (Figure 6A). Binding of MTF-1 to
the Zip10 promoter was increased by almost 3-fold after 1 h of zinc
treatment, and decreased to 25% after TPEN treatment. No
binding was detected using a non-specific IgG in place of the
MTF-1 antibody.
After establishing a relationship between MTF-1 DNA binding
and Zip10 repression, we investigated the possibility that MTF-1
physically obstructs Pol II movement, preventing active transcrip-
tion under conditions of adequate cellular zinc. ChIP assays were
utilized to immunoprecipitate the initiating and elongating forms
of Pol II. Further analysis by qPCR was conducted by
amplification of the TSS, exon 2, and exon 10 of Zip10. The c-
terminal domain (ctd) of Pol II is phosphorylated at Ser5 during
initiation of transcription at the promoter of active genes [29].
Under conditions of both zinc restriction and zinc supplementa-
tion of the cells, an equal amount of Ser5-P Pol II is associated
with the TSS of Zip10 (Figure 6B), even though levels of MTF-1 at
the promoter are higher under the supplemented conditions
(Figure 6A). Active gene transcription involves a switch from the
Ser5-P ctd to the Ser2-P ctd of Pol II for elongation. Amplification
of either exon 2 or exon 10 of Zip10, under zinc restricted (TPEN)
conditions show elongation activity of Pol II, through increased
Ser2-P Pol II association with the Zip10 gene (Figure 6C). In
contrast, the supplementation with 40 mM zinc produced no
evidence of Ser2-P or Ser5 Pol II association. Taken together, the
results from the Zip10 TSS and downstream exons show that Pol
II is recruited to the TSS even under zinc supplemented
conditions, but elongation occurs mainly under zinc-restricted
conditions. Furthermore, the Mt gene reacts positively to zinc
supplementation through activation and binding of MTF-1 to the
promoter. Therefore, Mt serves as a positive control for
transcriptional activity enhanced by MTF-1. In direct contrast
to the lack of Ser2-P association with Zip10, under zinc
supplemented conditions, but not zinc restricted conditions the
Ser2-P isoform of Pol II was detected downstream of the Mt TSS
(Figure 6D). These data suggest that MTF-1 binding to the MRE
at +07 of Zip10 creates an obstacle that prevents Pol II movement
from the TSS through the downstream remainder of the gene.
Zip10 functions as a zinc importer
To better understand the physiologic role of ZIP10, we first
identified its localization in AML12 hepatocytes. ZIP10 protein
was detected at the plasma membrane of AML12 hepatocytes as
well as primary hepatocytes (data not shown) under zinc-
deficient (ZnD) conditions (Figu r e7 A ) .As i m i l a ri n c r e a s eo f
ZIP10 at the plasma membrane of undifferentiated Neuro 2A
cells under zinc-deficient (ZnD) conditions was observed
(Figure 7A). Using MTmRNA as a sentinel indicator of
increased intracellular zinc, Zip10 knockdown with siRNA
markedly reduced MT expression (Figure 7B). Furthermore, by
using the zinc indicator FluoZin-3AM, we were able to detect
an increase in zinc-associated fluorescence that was not seen
when Zip10 protein expression was knocked down (Figure 7C).
These data reveal a role for ZIP10 in zinc uptake across the
plasma membrane of hepatocytes.
Discussion
In the present study we demonstrate that MTF-1 is an integral
part of ZIP10-related cellular zinc homeostasisin the liver and brain
both during zinc restriction and zinc excess. By using intact mice
and isolated murine hepatocytes we show that MTF-1 can act as a
repressor of Zip10 expression under normal physiologic levels of
zinc. Zinc depletion alleviates MTF-1 associated down regulation of
Zip10, allowing enhanced Zip10 transcriptional activation.
Figure 5. Zinc regulates Zip10 expression in an MTF-1 dependant manner. A 3 kb region of the Zip10 promoter was cloned in front of the
firefly luciferase gene of pGL4.11 and co-transfected with renilla luciferase into AML12 hepatocytes. For one series of experiments MTF-1 siRNA was
co-transfected with the luciferase vectors. In another series of experiments the MRE was mutated to a non-responsive StuI restriction site. Forty eight
h post-transfection, cells were incubated for 3 h with 40 mM zinc or 4 mM TPEN. The data represent relative mean firefly/ renilla activity from a
representative experiment that was replicated. Values with a different superscript are significantly different at P,0.05(*) or greater(**) (n=3 for
independent experiments).
doi:10.1371/journal.pone.0021526.g005
Repression of Zip10 expression by MTF-1 and Zinc
PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e21526A particularly interesting finding in our studies is the large
relative difference in Zip10 transcript abundance between the
brain and the liver, although the magnitude of responsiveness to
zinc deficiency is the same. Dietary zinc deprivation causes a
decrease in serum zinc concentration, but results in only small
reductions in the zinc context of most peripheral tissues [2].
Similarly, the concentration of zinc in the brain overall does not
vary much under zinc restriction and is therefore tightly regulated
[30,31]. However, considering the neurobiology of zinc [32],
region-specific localization of zinc occurs [33]. We observed
significant upregulation of ZIP10 expression in the striatum,
amygdala, caudate nucleus and substantia nigra as well as other
regions corresponding to components of the basal ganglia. These
regions play a significant role in movement control. Zinc exerts
many neurobiological effects, such as modulating functions of
neurotransmitter receptors in the brain [34]. Alterations in zinc
homeostasis in the brain may be involved in other neurological
diseases such as Alzheimer’s disease, Parkinson’s disease, and
amytrophic lateral sclerosis [32]. Inadequate dietary zinc intake
leads to changes in behavior such as reduced activity and
responsiveness to stimuli [35,36]. Zinc restriction during infancy
causes impaired learning behavior [37]. Therefore, using data
from the gwascentral.org database, we speculate that perturbations
in ZIP10 function or single nucleotide polymorphisms that cause
loss of function or restricted function may affect brain develop-
ment or the pathogenesis of neurological disorders. Furthermore,
the up-regulation of ZIP10 during conditions of zinc deficiency,
particularly during development, may have deleterious effects on
neurological processes. The potential for increased zinc influx via
ZIP10 controlled import may raise issues about the known
relationship between excess zinc and neural cell death [38].
For many years, MTF-1 was thought of as purely a positive
promoter of zinc-induced transcription. It was originally identified
as the transcription factor responsible for activation of the sentinel
zinc-responsive gene, Mt, which helps maintain cellular zinc
balance [10,39]. Additionally, zinc-induced MTF-1 was found to
up-regulate the primary zinc exporter ZnT1 (SLC30a1) [6,7], as
well as other genes involved in detoxification of heavy metals [13].
The essentiality of MTF-1-dependent gene expression became
apparent when the null mutation of the gene was found to be
embryonic lethal [12]. By using a liver-specific conditional
knockout of MTF-1, the first indication of a repressive role for
MTF-1 in heavy-metal dependant gene expression was found [13].
Specifically, the liver-specific ablation of the transcription factor
allowed for increased expression of Zip10.
Analysis of Zip10 mRNA by 59 RACE revealed one gene
transcript and an MRE 17 bp downstream of the lone TSS. Until
recently, MREs were primarily thought to lie upstream of the TSS
and promote heavy-metal gene expression, as is the case for MT
Figure 6. Transcriptional elongation by Pol II occurs during
zinc deficiency, but not with zinc supplementation. (A)
Association of MTF-1 with the Zip10 promoter was analyzed by using
ChIP. AML12 hepatocytes were incubated with zinc or TPEN as
indicated in A. The ratio of IP to input DNA was quantified by qRT-
PCR. Values are significantly different at P,0.05. All data are expressed
as mean 6 SD. (B) ChIP analysis of Pol II throughout the Zip10 gene by
using an antibody specific for the Ser5 phosphorylated form of Pol II,
3 h after incubation of the AML12 hepatocytes with 40 mM zinc or 4 mM
TPEN. (C) ChIP analysis of the elongating form of Pol II, phosphorylated
at Ser2. Cells were treated as in A.( D) Analysis of Pol II association
throughout the Mt gene. A non-specific rabbit IgG was used as a
negative control for both B & C. Data for B–D were plotted as the ratio
of immunoprecipitated DNA to a 1:20 dilution of input DNA. A
representative experiment is shown and replicated two times.
Background immunoprecipitation levels were always below a ratio of
0.01 (to input DNA). Values with a different superscript are significantly
different at P,0.05 (n=3).
doi:10.1371/journal.pone.0021526.g006
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that while most MREs lie upstream of the TSS in mouse genes, a
significant portion can be found in introns, and some in exons
[40]. Another report extended these findings by using bioinfor-
matics and ChIP to demonstrate MTF-1 binding to MREs located
downstream of the translation start site of the Selh and TXNRD2
genes [41]. For our experiments we used ChIP to show zinc-
induced MTF-1 association with the MRE located within the first
untranslated exon of the Zip10 gene. Similar results have been
observed in zebrafish where zinc induces repression of Zip10
expression via binding to an intronic MRE cluster [19]. Binding of
MTF-1 to this downstream MRE provides a degree of plasticity in
regulation of zinc homeostasis by regulating gene transcription in
the direction opposite to the usual mechanism. An analogous
observation has been made for the low-affinity zinc uptake
transporter gene ZRT2 of S. cerevisiae. The zinc-responsive
transcriptional activator Zap1 binds to an element downstream
of the ZRT2 TATA box, repressing gene expression [42].
As a mechanism to explain the repression of Zip10 during zinc
adequate conditions of hepatocytes, we hypothesized that MTF-1
acts as a transcriptional repressor by obstructing movement of Pol
II from the Zip10 TSS. Transcription is a complex multistep
process involving sequence-specific activators that recruit Pol II
and general transcription factors (GTFs) to the TSS for formation
of the pre-initiation complex (PIC). Transcription initiation begins
with TFIIH (a GTF) phosphorylating Ser5 residues in the
carboxy-terminal domain of Rpb1, the large subunit of Pol II
[29]. However, in some cases Pol II stalls and does not continue to
transcription elongation, but instead remains poised on the TSS
allowing another level of transcriptional control [43]. Develop-
mental and heat shock genes are examples of genes regulated by
promoter-proximal pausing of Pol II [44,45]. Zinc deficiency is
associated with diverse disorders, including impaired immunity,
retarded growth, brain development disorders and delayed wound
healing. Therefore, a zinc transporter that is responsive to zinc
e.g., Zip10 could be considered critical for maintaining zinc
homeostasis and would benefit from a rapid transcription response
mechanism to zinc deficiency such as Pol II pausing. This is
opposite to what is found for another MTF-1 regulated gene, Mt,
upon zinc restriction. We show here that under the zinc restricted,
adequate, and supplemental conditions used in these experiments,
Pol II is actively recruited to the Zip10 TSS and is poised for
transcription initiation as indicated by Ser5 phosphorylation.
However, for gene transcription to occur productive elongation
must ensue. This entails a shift from Ser5 phosphorylation to Ser2
phosphorylation, and recruitment of various elongation factors.
Only under the conditions of zinc restriction could we detect Ser2
phosphorylated Pol II. We therefore propose that when cellular
zinc is adequate, MTF-1 represses Zip10 expression by interfering
Figure 7. ZIP10 localizes to the plasma membrane and
facilitates zinc uptake. (A) AML12 hepatocytes and undifferentiated
Neuro 2A cells were incubated without (ZnA) or with 4 mM TPEN (ZnD).
AML12 hepatocytes were incubated with the affinity purified ZIP10
antibody and detected by addition of anti-rabbit IgG-Alexa 488
conjugate. The Neuro 2A cells were incubated with the same ZIP10
antibody and anti-rabbit IgG Alexa 594 conjugate. (B)A M L 1 2
hepatocytes were transfected with Zip10 siRNA and 48 h later were
incubated with 0, 40, or 100 mM zinc for 30 min. MT mRNA was
analyzed by qRT-PCR, and normalized to 18s rRNA. (C) Hepatocytes
were transfected with Zip10 siRNA or negative control siRNA as above.
Intracellular labile zinc was detected with FluoZin-3AM fluorescence
assay and reported as relative fluorescence units. Values with a different
superscript are significantly different at P,0.05 (n=3). (D) Model
depicting the influence of the MTF-1 transcription factor based upon
placement of MRE consensus sequence. Zinc occupancy causes MTF-1
translocation to the nucleus. MRE placement in the MT or ZnT1 genes
allows Pol II movement for transcription initiation and elongation. MRE
placement in Zip10 allows initiation, but MTF-1 binding to the MRE
prevents movement of Pol II preventing elongation. During zinc
restriction MTF-1 does not move to the nucleus allowing Zip10
transcription to proceed.
doi:10.1371/journal.pone.0021526.g007
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impeding the movement of Pol II.
Many reports have suggested an involvement of zinc and/or
zinc transporters in cancer development and progression, such as
carcinomas of the liver, lymph node, and breast [46]. The levels of
zinc in the serum or affected tissues of cancer patients, is decreased
in various malignancies. However, in breast cancer patients the
zinc levels are lower in the serum and elevated in the malignant
tissues [47,48]. In a study by Kagara et al., highly metastatic and
advanced breast cancers showed higher expression of ZIP10 than
non-metastatic breast cancers [49]. Furthermore, the study
suggests that in advanced breast cancers, which express high
levels of ZIP10, larger amounts of zinc are transported into the cell
cytosol from the serum leading to metastasis. In the present study,
we show that ZIP10 localizes to the plasma membrane of
hepatocytes and zinc transport is inhibited by Zip10 siRNA.
Additionally, preliminary data collected during this study suggests
that knocking down Zip10 abundance inhibits E2F (a regulator of
cell cycle progression) [50] activity (Figure S3), and decreases
expression of the proliferative marker genes thymidine kinase (tk)
and dihydrofolate reductase (dhfr) [51] (Lichten et al., unpublished
observations). Taken together, these findings may reveal a role for
Zip10 in not only cancer metastasis, but in cell cycle progression,
and proliferation.
Our finding of the high Zip10 expression in mouse brain
suggests that ZIP10 transport may be critical to maintaining
neuronal functions and that the regional expression has teleologic
relevance. Zinc is believed to have second messenger functions in
brain and the ZIP transporters are believed to be key to cellular
homeostasis [16,52]. Of relevance is the suggestion of the
evolutionary link of ZIP5, 6, and 10 ectodomains with the prion
proteins [53]. This phylogenetic connection could lead to an
understanding of ZIP10 as a factor in neurologic disease.
In summary, the experiments described here using intact mice
and isolated murine hepatocytes show that MTF-1 is an integral
part of ZIP10-related cellular zinc homeostasis in the liver both
during zinc restriction and zinc excess. The results show that
MTF-1 has physiologic significance and can act as a repressor of
Zip10 under normal cellular levels of labile zinc. Upon reducing
cellular zinc, repression is lost, as MTF-1 is not translocated to the
nucleus allowing enhanced Zip10 transcriptional activation. The
apparent differential mode of MTF-1 action, resides in the
genomic placement of the MRE downstream of the Zip10
transcription start site. The results also show that ZIP10 is a
new target to investigate dietary influences on zinc metabolism by
the liver and within specific regions of the brain and therein could
help to elucidate the neurobiological effects of zinc that have been
elusive thus far.
Supporting Information
Figure S1 The relative difference in Zip10 expression
between liver and brain tissues. The transcript abundance of
Zip10 from each tissue was analyzed by qRT-PCR. Zip10
expression was normalized to 18s rRNA. n=5.
(TIF)
Figure S2 59 RACE analysis of the Zip10 transcription
start site. Total RNA was collected from liver tissue and reverse
transcribed to cDNA using transcript specific primers for Zip10
mRNA. The cDNA was then cloned and sequenced. (A) The
sequence obtained from the public record matches the sequence
obtained by 59RACE. (B) Agarose gel analysis of 59 RACE
product.
(TIF)
Figure S3 Zip10 siRNA affects signalling pathways
related to proliferation. The Cignal 45 reporter array
(QIAGEN) was used to identify signalling pathways that may be
activated or repressed by knocking down Zip10 abundance. The
top five activated and repressed pathways are shown.
(TIF)
Table S1 Average Ct values for Zip transporter genes.
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